Souhaitez-vous accéder aux communiqués récents ?

Marvel Biosciences to participate in 2nd Neuroscience Innovation Partnering & Licensing Summit, allowing Marvel to showcase its progress on global stage

CEO Gareth Sheridan appears as guest on the Jack Neel Podcast

Dr Falk and Renexxion selected for late-breaking oral presentation at this year’s DDW, for data from global P2b study of naronapride in gastroparesis.

Marvel Biosciences Corp. announces it has identified two lead pediatric-friendly liquid formulations of its patented lead compound, MB-204.

Salt Lake City, UT, April 09, 2026 (GLOBE NEWSWIRE) -- TAP Real Estate (OTC: RWAX) is pleased to welcome Jeff Jarrard as Chief Technology Officer (CTO), where he will lead the buildout and...

China National Intellectual Property Administration has granted a patent covering potency assay methods for assessing human mesenchymal stem cells (MSCs).

Patent validates AI-powered platform for moving cost estimation and marketplace matching technology

Marvel announces financial and strategic backing from 5 Horizons Ventures to support its upcoming Phase 1 clinical trial of patented lead asset MB-204

NorthStrive Defense Tech Acquires Multi-Domain Drone Payload Technology Option for Defense and Commercial Applications

The USPTO issued Xeriant (OTCQB: XERI) a Notice of Allowance covering its proprietary multilayered fire-resistant composite and method of making same.